Asia Pacific home healthcare device and equipment market will grow by 9.0% annually with a total addressable market cap of $133.0 billion over 2021-2030 owing to the aging population worldwide, the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance.

Highlighted with 42 tables and 57 figures, this 135-page report “Asia Pacific Home Healthcare Device and Equipment Market 2020-2030 by Product Type (Therapeutic, Patient Monitoring, Mobility Assist), Disease, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific home healthcare device and equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific home healthcare device and equipment market in every aspect of the classification from perspectives of Product Type, Disease, Distribution Channel, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Therapeutic Equipment

o Home Respiratory Therapy Equipment

 Oxygen Delivery Equipment (ODE) (ODE is further split into Home Liquid Oxygen Containers, Oxygen Cannula, Oxygen Concentrators, Other Home Oxygen Delivery Equipment)

 Continuous Positive Airways Pressure Equipment (CPAP) (further segmented into CPAP Masks & Related Interfaces, CPAP Machines, CPAP Accessories)

 Humidifiers

 Nebulizers

 Ventilators

o Home IV Equipment

 IV Pumps

 IV Administration Sets

 Premixed IV Devices

 IV Catheters

 Injection Devices

 IV Accessories

o Home Dialysis Equipment

 Home Hemolysis Products

 Home Peritoneal Dialysis

o Other Home Therapeutic Equipment

 Home Physical Therapy Equipment

 Home Automated External Defibrillators

 Home Enteral Feeding Products

 Home Negative Pressure Wound Therapy Devices

 Home Braces & Related Products

 Home Muscle & Nerve Stimulators

• Patient Monitoring Equipment

o Blood Pressure Monitors

o Blood Glucose Monitors

o Coagulation Monitors

o Baby Monitors

o Heart Rate Monitor

o Apnea Monitors

o Electronic Thermometer

o Peak Flow Monitors

o Holter Monitors

o Remote Patient Monitoring Systems

o Real-Time Telemedicine Systems

o Other Patient Monitoring Equipment

• Mobility Assist & Patient Support Equipment

o Mobility Assist Equipment

 Wheelchairs

 Scooters

 Canes & Crutches

 Walkers & Rollators

 Stair Lifts

o Home Healthcare Furniture

 Lift Chairs

 Medical Beds

 Other Home Healthcare Furniture

o Bathroom Safety Equipment

 Commodes

 Shower Chairs

 Elevated Toilet Seats

 Bars, Grips, & Rails

Based on Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Diabetes

• Motion Impairments

• Respiratory Diseases

• Sleep Disorder

• Kidney Failure

• Hypertension

• Other Diseases

Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Retail Pharmacy

• Hospitals

• Online Stores

Geographically, the following national/local markets are fully investigated:

• Japan

• China

• South Korea

• Australia

• India

• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product Type, Disease, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories Inc.

Baxter International Inc.

Becton, Dickinson and Co.

Braun Melsungen AG

CAIRE Inc.

ConvaTec Group plc

Drive DeVilbiss Healthcare

Fresenius Medical Care Holdings, Inc.

General Electric Company

Hill-Rom Holdings, Inc.

Inogen, Inc.

Invacare Corporation

Johnson & Johnson

Koninklijke Philips N.V.

Medtronic Plc

O2 Concepts, LLC

ResMed Inc.

Smith & Nephew Plc

Stryker Corp.

Sunrise Medical (US) LLC

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on World Economy 21

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 28

2.4 Emerging Opportunities and Market Trends 31

2.5 Porter’s Fiver Forces Analysis 35

3 Segmentation of Asia Pacific Market by Product Type 41

3.1 Market Overview by Product Type 41

3.2 Therapeutic Equipment 43

3.2.1 Home Respiratory Therapy Equipment 45

3.2.2 Home IV Equipment 47

3.2.3 Home Dialysis Equipment 49

3.2.4 Other Home Therapeutic Equipment 50

3.3 Patient Monitoring Equipment 52

3.3.1 Blood Pressure Monitors 54

3.3.2 Blood Glucose Monitors 55

3.3.3 Coagulation Monitors 56

3.3.4 Baby Monitors 57

3.3.5 Heart Rate Monitor 58

3.3.6 Apnea Monitors 59

3.3.7 Electronic Thermometer 60

3.3.8 Peak Flow Monitors 61

3.3.9 Holter Monitors 62

3.3.10 Remote Patient Monitoring Systems 63

3.3.11 Real-Time Telemedicine Systems 64

3.3.12 Other Patient Monitoring Equipment 65

3.4 Mobility Assist & Patient Support Equipment 66

3.4.1 Mobility Assist Equipment 68

3.4.2 Home Healthcare Furniture 69

3.4.3 Bathroom Safety Equipment 70

4 Segmentation of Asia Pacific Market by Disease 71

4.1 Market Overview by Disease 71

4.2 Diabetes 73

4.3 Motion Impairments 74

4.4 Respiratory Diseases 75

4.5 Sleep Disorder 76

4.6 Kidney Failure 77

4.7 Hypertension 78

4.8 Other Diseases 79

5 Segmentation of Asia Pacific Market by Distribution Channel 80

5.1 Market Overview by Distribution Channel 80

5.2 Retail Pharmacy 82

5.3 Hospitals 83

5.4 Online Stores 84

6 Asia-Pacific Market 2019-2030 by Country 85

6.1 Overview of Asia-Pacific Market 85

6.2 Japan 88

6.3 China 91

6.4 Australia 94

6.5 India 97

6.6 South Korea 99

6.7 Rest of APAC Region 101

7 Competitive Landscape 103

7.1 Overview of Key Vendors 103

7.2 New Product Launch, Partnership, Investment, and M&A 107

7.3 Company Profiles 108

Abbott Laboratories Inc. 108

Baxter International Inc. 110

Becton, Dickinson and Co. 111

Braun Melsungen AG 112

CAIRE Inc. 113

ConvaTec Group plc 114

Drive DeVilbiss Healthcare 115

Fresenius Medical Care Holdings, Inc. 116

General Electric Company 117

Hill-Rom Holdings, Inc. 118

Inogen, Inc. 119

Invacare Corporation 120

Johnson & Johnson 121

Koninklijke Philips N.V. 122

Medtronic Plc 123

O2 Concepts, LLC 124

ResMed Inc. 125

Smith & Nephew Plc 126

Stryker Corp. 127

Sunrise Medical (US) LLC 128

8 Investing in Asia Pacific Market: Risk Assessment and Management 129

8.1 Risk Evaluation of Asia Pacific Market 129

8.2 Critical Success Factors (CSFs) 132

Related Reports and Products 135

Methodology/Research Approach

Research Programs/Design

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources